Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of HBV Reinfection After Liver Transplantation Using Entecavir Monotherapy After Short-term HBIg Administration: A Pilot Study

NCT01046799 is registered in ClinicalTrials.gov with HepNet Study House, German Liverfoundation as lead sponsor.

NCT NCT01046799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01046799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of HBV Reinfection After Liver Transplantation Using Entecavir Monotherapy After Short-term HBIg Administration: A Pilot Study
Lead sponsor
HepNet Study House, German Liverfoundation
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
October 31, 2014
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, liver disease, liver transplantation